Scientists working in university and national labs are increasingly interested in launching startup companies as vehicles to actively translate their research derived innovations from lab-to-market. These commercial aspirations are routinely hindered by the belief that great technology alone provides a sufficient basis for a great startup company. This view often leads to a narrow business focus and protracted or failed attempts to secure critical resources, including risk capital investment.
This blog post intends to help scientific entrepreneurs develop a more holistic view of their startup and to understand what they can do to successfully attract investors at various early stages of their company, from pre-seed to series A.
Premium content locked!
Join our mailing list and get instant access.